Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Springer Nature Link
Log in

Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Metastasis remains a major cause of mortality in head and neck squamous cell carcinoma (HNSCC). Current clinicopathological features have shown limited predictability for the risk of distant metastasis in individual patients, and therefore more accurate and reliable markers are needed. The aim of this study was to investigate the ability of various molecular markers present in primary tumors to predict the risk of developing distant metastasis. Restrictive clinical criteria were applied for patient selection in order to carry out a case–control study with comparable clinical features on a group-wide basis and a similar risk of metastasis. All patients were surgically treated (with postoperative radiotherapy when appropriate) and classified as stage IV disease. Immunohistochemical analysis was performed for a panel of proteins known to participate in cellular processes relevant to metastatic dissemination (E-cadherin, annexin A2, cortactin, FAK, EGFR, p53, and p-AKT). Results showed that the loss of E-cadherin expression was significantly correlated with the risk of distant metastasis (P = 0.002; log-rank test), while the loss of annexin A2 expression was nearly statistically significant (P = 0.06). None of the other protein markers assessed were associated with the development of distant metastasis. Therefore, according to our data the loss of epithelial adhesion seems to play a central role in the development of metastasis in HNSCC, and more importantly, immunohistochemical assessment of key proteins involved in cell adhesion regulation, such as E-cadherin could represent a useful tool to evaluate easily and routinely the metastatic potential of these carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pulte D, Brenner H (2010) Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 15:994–1001

    Article  PubMed  Google Scholar 

  2. Calhoun KH, Fulmer P, Weiss R, Hokanson JA (1994) Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 104:1199–1205

    Article  CAS  PubMed  Google Scholar 

  3. Kowalski LP, Carvalho AL, Martins Priante AV, Magrin J (2005) Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma. Oral Oncol 41:534–541

    Article  PubMed  Google Scholar 

  4. Ferlito A, Shaha AR, Sliver CE, Rinaldo A, Mondin V (2001) Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 63:202–207

    Article  CAS  PubMed  Google Scholar 

  5. Li X, Di B, Shang Y, Zhou Y, Cheng J, He Z (2009) Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. Eur J Surg Oncol 35:1348–1353

    Article  CAS  PubMed  Google Scholar 

  6. Bhatia R, Bahadur S (1987) Distant metastasis in malignancies of the head and neck. J Laryngol Otol 101:925–928

    Article  CAS  PubMed  Google Scholar 

  7. Alvi A, Johnson JT (1997) Development of distant metastases after treatment of advanced stage head and neck cancer. Head Neck 19:500–505

    Article  CAS  PubMed  Google Scholar 

  8. Leon X, Quer M, Orus C, del Prado Venegas M, Lopez M (2000) Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22:680–686

    Article  CAS  PubMed  Google Scholar 

  9. Coca-Pelaz A, Rodrigo JP, Suárez C (2012) Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas. Head Neck 34:771–775

    Article  PubMed  Google Scholar 

  10. Pfister D, Laurie SA, Weinstein GS et al (2006) American Society of Clinical Oncology Practice Guidelines for the use of larynx preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3604–3693

    Article  Google Scholar 

  11. Bhave SL, Teknos TN, Pan Q, James AG, Solove RJ (2011) Molecular parameters of head and neck cancer metastasis. Crit Rev Eukaryot Gene Expr 21:143–153

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J (2011) Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol 99:344–348

    Article  CAS  PubMed  Google Scholar 

  13. Braakhuis BJM, Senft A, de Bree R, de Vries J, Ylstra B, Cloos J, Kuik DJ, Leemans CR, Brakenhoff RH (2006) Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma. J Clin Pathol 59:1254–1260

    Article  CAS  PubMed  Google Scholar 

  14. Bleijerveld OB, Brakenhoff RH, Schaaij-Visser TB, Damen JM, Altelaar AF, Heck AJ, Leemans CR, Slijper M (2011) Protein signatures associated with tumor cell dissemination in head and neck cancer. J Proteomics 74:558–566

    Article  CAS  PubMed  Google Scholar 

  15. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847

    Article  CAS  PubMed  Google Scholar 

  16. Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333–339

    Article  CAS  PubMed  Google Scholar 

  17. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W (1991) E-cadherin-mediated cell–cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173–185

    Article  CAS  PubMed  Google Scholar 

  18. Thiery JP (2002) Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442–454

    Article  CAS  PubMed  Google Scholar 

  19. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68:3645–3654

    Article  CAS  PubMed  Google Scholar 

  20. Yoo JY, Yang SH, Lee JE, Cho DG, Kim HK, Kim SH, Kim IS, Hong JT, Sung JH, Son BC, Lee SW (2012) E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model. J Neurooncol 109:219–227

    Article  CAS  PubMed  Google Scholar 

  21. Chen X, Wang Y, Xia H, Wang Q, Jiang X, Lin Z, Ma Y, Yang Y, Hu M (2012) Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis. Mol Biol Rep 39:6707–6714

    Article  CAS  PubMed  Google Scholar 

  22. von Burstin J, Eser S, Paul MC, Seidler B, Brandl M, Messer M, von Werder A, Schmidt A, Mages J, Pagel P, Schnieke A, Schmid RM, Schneider G, Saur D (2009) E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 137:361–371

    Article  Google Scholar 

  23. Fan L, Wang H, Xia X, Rao Y, Ma X, Ma D, Wu P, Chen G (2012) Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression. Oncol Lett 4:1225–1233

    CAS  PubMed Central  PubMed  Google Scholar 

  24. Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z (2008) Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer 113:97–107

    Article  CAS  PubMed  Google Scholar 

  25. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK (2008) Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112:2088–2100

    Article  CAS  PubMed  Google Scholar 

  26. Bosch FX, Andl C, Abel U, Kartenbeck J (2005) E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int J Cancer 114:779–790

    Article  CAS  PubMed  Google Scholar 

  27. Rodrigo JP, Domínguez F, Alvarez C, Manrique C, Herrero A, Suárez C (2002) Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 38:1059–1064

    Article  CAS  PubMed  Google Scholar 

  28. Chung CY, Murphy-Ullrich JE, Erickson HP (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 7:883–892

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Yamada A, Irie K, Hirota T, Ooshio T, Fukuhara A, Takai Y (2005) Involvement of the annexin II-S100A10 complex in the formation of E-cadherin–based adherens junctions in Madin–Darby canine kidney cells. J Biol Chem 280:6016–6027

    Article  CAS  PubMed  Google Scholar 

  30. Waisman DM, Annexin II (1995) Tetramer: structure and function. Mol Cell Biochem 149–150:301–322

    Article  PubMed  Google Scholar 

  31. Hayes MJ, Shao D, Bailly M, Moss SE (2006) Regulation of actin dynamics by annexin 2. EMBO J 25:1816–1826

    Article  CAS  PubMed  Google Scholar 

  32. Pena-Alonso E, Rodrigo JP, Parra IC, Pedrero JM, Meana MV, Nieto CS, Fresno MF, Morgan RO, Fernandez MP (2008) Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett 263:89–98

    Article  CAS  PubMed  Google Scholar 

  33. Rodrigo JP, Lequerica-Fernández P, Rosado P, Allonca E, García-Pedrero JM, de Vicente JC (2011) Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma. Head Neck 33:1708–1714

    Article  PubMed  Google Scholar 

  34. Kelley LC, Shahab S, Weed SA (2008) Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer. Clin Exp Metastasis 25:289–304

    Article  CAS  PubMed  Google Scholar 

  35. Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM (2009) Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 217:5123–5165

    Article  Google Scholar 

  36. Canel M, Secades P, Rodrigo JP, Cabanillas R, Herrero A, Suarez C, Chiara MD (2006) Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number. Clin Cancer Res 12:3272–3279

    Article  CAS  PubMed  Google Scholar 

  37. Rodrigo JP, Álvarez-Alija G, Menéndez ST, Mancebo G, Allonca E, García-Carracedo D, Fresno MF, Suárez C, García-Pedrero JM (2011) Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy. Cancer Prev Res 4:1333–1341

    Article  CAS  Google Scholar 

  38. de Vicente JC, Rodrigo JP, Rodriguez-Santamarta T, Lequerica-Fernández P, Allonca E, García-Pedrero JM (2012) Cortactin and focal adhesion kinase as predictors of cancer risk in patients with premalignant oral epithelial lesions. Oral Oncol 48:641–646

    Article  PubMed  Google Scholar 

  39. Lee MY, Chou CY, Tang MJ, Shen MR (2008) Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 14:4743–4750

    Article  CAS  PubMed  Google Scholar 

  40. Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y (2010) Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29:4947–4958

    Article  CAS  PubMed  Google Scholar 

  41. Wang H, Fan L, Wei J, Weng Y, Zhou L, Shi Y, Zhou W, Ma D, Wang C (2012) Akt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cells. PLoS ONE 7:e46888

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L (2002) Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62:7350–7356

    CAS  PubMed  Google Scholar 

  43. Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ (1998) Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90:824–832

    Article  CAS  PubMed  Google Scholar 

  44. Massarelli E, Liu DD, Lee JJ, El-Naggar AK, Lo Muzio L, Staibano S, De Placido S, Myers JN, Papadimitrakopoulou VA (2005) Akt activation correlates with adverse outcome in tongue cancer. Cancer 104:2430–2436

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from Fondo de Investigación Sanitaria CP07/00032 and PI10/00157 (to JMGP) and PI11/00929 (to CS) ISCIII, Fondos FEDER, RTICC (RD12/0036/0015) and Obra Social Cajastur-IUOPA.

Author information

Authors and Affiliations

  1. Laboratorio 2 ORL, Department of Otolaryngology, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, 33006, Oviedo, Spain

    Juan P. Rodrigo, Patricia Martínez, Eva Allonca, Laura Alonso-Durán, Carlos Suárez & Juana María García-Pedrero

  2. Department of Pathology, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain

    Aurora Astudillo

Authors
  1. Juan P. Rodrigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eva Allonca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura Alonso-Durán
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carlos Suárez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aurora Astudillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Juana María García-Pedrero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Juan P. Rodrigo or Juana María García-Pedrero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodrigo, J.P., Martínez, P., Allonca, E. et al. Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas. Clin Exp Metastasis 31, 317–325 (2014). https://doi.org/10.1007/s10585-013-9630-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-013-9630-5

Keywords

Search

Navigation